China-based healthcare-focused venture capital firm Quan Capital has closed its second fund – Quan Venture Fund II – with $275 million in commitments, according to an AVCJ report.
The amount raised, however, is lower than the $300-million target that the firm set when it launched the fund in August 2018. The firm was established by the founder of US-listed Chinese drug developer Zai Lab.
